The Long-term Effect on Intestinal Absorption and Safety of Treatment With Glepaglutide in Patients With Short Bowel Syndrome
Clinical trial NCT04991311 · COMPLETED
Trial details
- NCT number
- NCT04991311
- Sponsor
- Zealand Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-10
- Primary completion
- 2023-02-02
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.